The global proteomics market is anticipated to witness substantial growth, with an expected value of USD 70.8 billion by the year 2030. According to recent market analysis, the market size for proteomics was estimated at USD 25.3 billion in 2022, indicating a robust upward trajectory with a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period from 2023 to 2030.

Proteomics, a rapidly evolving field of molecular biology and bioinformatics, focuses on the comprehensive study of proteins, their structures, functions, and interactions within biological systems. Key factors driving the growth of the proteomics market include:

Advancements in Mass Spectrometry and Protein Analysis Technologies: Continuous advancements in mass spectrometry instrumentation, protein separation techniques, and bioinformatics tools are driving innovation in proteomics workflows, enabling high-throughput protein identification, quantification, and characterization, driving market growth and adoption.

Growing Applications in Drug Discovery and Development: The increasing use of proteomics in drug discovery and development for target identification, biomarker discovery, and drug efficacy assessment is driving market growth and investment in proteomics-based approaches for precision medicine, personalized therapeutics, and novel drug candidates.

Clinical Applications in Personalized Medicine and Diagnostics: The expanding applications of proteomics in clinical research, diagnostics, and personalized medicine initiatives for disease diagnosis, prognosis, and treatment selection are driving market growth and adoption of proteomics-based assays, clinical proteomics platforms, and companion diagnostics.

Biopharmaceutical Manufacturing and Quality Control: The application of proteomics in biopharmaceutical manufacturing and quality control for protein characterization, process monitoring, and product quality assurance is driving demand for proteomics solutions, mass spectrometry services, and analytical instrumentation in biopharmaceutical industries.

Precision Agriculture and Crop Improvement: The adoption of proteomics in agriculture and plant sciences for crop improvement, trait characterization, and agricultural sustainability initiatives is driving market growth and investment in proteomics-based approaches for crop protection, genetic crop enhancement, and agrochemical development.

Translational Research and Collaborative Initiatives: Increasing collaboration between academic institutions, research organizations, and biotechnology companies in translational research initiatives, multi-omics integration, and systems biology approaches is driving innovation and market expansion in proteomics research, enabling cross-disciplinary insights and applications.

KEY SEGMENTS

By Product

  • Instruments
  • Reagents & Consumables
  • Services

By Technology

  • Microarray Instruments
  • X-Ray Crystallography
  • Spectroscopy
  • Chromatography
  • Protein Fractionation Systems
  • Electrophoresis
  • Surface Plasma Resonance Systems

By Application

  • Drug Discovery
  • Clinical diagnostics
  • Others

The major key players are Illumina, Inc., Agilent Technologies, Inc., Bio - Rad Laboratories, Inc., GE Healthcare, Thermo Fisher Scientific, Inc., Bruker Corporation, F. Hoffmann-La Roche Ltd., Promega Corp., Merck KGaA., Danaher, and Others.

As the global life sciences community continues to prioritize protein research, biomarker discovery, and precision medicine approaches, the proteomics market is expected to witness sustained growth, driven by technological innovation, clinical adoption, and expanding applications across diverse research, diagnostic, and therapeutic domains.

Other Reports You May Like:

Digital Therapeutics Market Growth

Biomarkers Market Growth

Oncology Drugs Market Growth

Smart Healthcare Market Growth

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com